Clicky

Allogene Therapeutics, Inc.(ALLO) News

Date Title
Oct 3 Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In Now
Sep 30 Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference
Sep 26 Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence
Sep 18 IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?
Sep 14 Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This Cancer Stock
Jun 20 Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
Jun 12 Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound?
May 23 Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
May 14 Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
May 14 Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 13 Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
May 13 Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
May 13 Allogene Therapeutics Reports First Quarter 2024 Financial ResultsĀ and Business Update
May 10 CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?
May 6 Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Apr 26 Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Apr 25 Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 24 Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
Apr 11 3 Meme Stocks to Sell and Replace With Meme Coins
Apr 9 Allogene Therapeutics Announces Q2 Investor Conference Participation